REGGIE PENNYPACKER: Open Payments
NPI 1275960304 · DUNCAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 37 payments from 11 companies in 2025. Trend: 2023 $806 · 2024 $900 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $293 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| PFIZER INC. | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Lilly USA, LLC | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| Abbott Laboratories | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Korlym, GVOKE HYPOPEN, FARXIGA, BREZTRI, NURTEC ODT, Kerendia, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across OK — which companies pay providers there.
